Lymphangitic carcinomatosis is the infiltration and inflammation of lymphatic vessels secondary to the spread of malignancy from a primary site. Pulmonary lymphangitic carcinomatosis almost always represents the clinical form of lymphangitic carcinomatosis and denotes an end-stage malignancy with poor prognosis. This activity covers the etiology, clinical features, diagnostic evaluation and management of suspected pulmonary lymphangitic carcinomatosis and highlights the role of the interprofessional team in delivering the best outcome in a given patient.

**Objectives:**
- Describe the etiology of lymphangitic carcinomatosis.
- Outline the evaluation of lymphangitic carcinomatosis.
- Outline the management options available for lymphangitic carcinomatosis.